# Boxer Capital

Source: https://onco.cc/companies/boxer-capital/  
OnCo record `boxer-capital` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A San Diego biotech investment firm that backs precision medicine companies from private rounds through public listing. Its venture highlights include cancer drug developers Mirati, G1 Therapeutics, Tango and Elevation Oncology.

## Summary

Boxer Capital Management, at 12860 El Camino Real, San Diego, calls itself 'a full life cycle investment firm, committed to fundamental, research-based investing in specialised and precision medicine companies across private and public markets'. Its venture highlights page states that it has invested in 74 private companies since 2014, led or co-led 14 of them, and seen 51 liquidity events (IPOs, public access or acquisitions), noting that earlier investments were made by Boxer Capital, LLC before a reorganisation into Boxer Capital Management, LLC. Oncology names on that page include Mirati Therapeutics (KRAS inhibitor developer), G1 Therapeutics, Tango Therapeutics (synthetic lethality), Elevation Oncology, Blueprint Medicines, Relay Therapeutics and Revolution Medicines.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: vc
- HQ: San Diego, CA
- Type: investor
- Website: https://www.boxercap.com/

## Notes

- Founding year not stated on the site; omitted.

## Sources

- Official website: https://www.boxercap.com/
- Venture highlights: https://www.boxercap.com/venture-highlights/

## Connected records

- companies: [Blueprint Medicines](https://onco.cc/companies/blueprint-medicines/), [Relay Therapeutics](https://onco.cc/companies/relay-therapeutics/), [Revolution Medicines](https://onco.cc/companies/revolution-medicines/), [Tango Therapeutics](https://onco.cc/companies/tango-therapeutics/)

---
JSON: https://onco.cc/api/v1/entities/boxer-capital.json